Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Trial Type:  Prevention
Treatment/Intervention:  smoking cessation intervention
Results 1-16 of 16 for your search:
Start Over
Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit
Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: STUDY00001602, NCI-2015-01331, AD-1310-08709, NCI-2015-00937, NCT02244918
Culturally Tailored Smoking Cessation Intervention in Increasing Smoking Cessation Rates among Latino Smokers
Status: Active
Phase: Phase II, Phase I
Type: Prevention
Age: 18 and over
Trial IDs: 2015-0585, NCI-2016-00193, NCT02596711
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Status: Active
Phase: Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 1R01CA141531-01, NCI-2016-00485, 1R01CA141531, NCT01067599
Mindfulness-Based Addiction Treatment in Treating Patients With Nicotine Dependence
Status: Active
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: 2004-0988, NCI-2012-02081, NCT00297479
Capitalizing on a Teachable Moment to Promote Smoking Cessation
Status: Active
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: MCC# 17952, NCI-2014-02247, 14.10.0023, 4KB05, NCT02276664
Mobile Smoking Cessation Interventions in Reducing Smoking in Participants with Human Immunodeficiency Virus (HIV)
Status: Active
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: 2014-0509, NCI-2014-02572, NCT02302859
Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Status: Active
Phase: No phase specified
Type: Behavioral study, Health services research, Prevention
Age: 18 and over
Trial IDs: MCC-18127, NCI-2015-00638, 15.02.0024, 18127, NCT02416011
Nicotine Patches With or Without Behavioral Therapy in Reducing Cigarette Smoking and Binge Drinking in Young Adults
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 30
Trial IDs: 10-000432, NCI-2010-01881, NCT01184261
Varenicline in Improving Adolescent Smoking Cessation
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 14 to 21
Trial IDs: PRO00014398, NCI-2014-01053, 101928, U01 DA031779, NCT01509547
Mobile Phone Text Messaging Intervention in Reducing Smoking in Older Adults in Rural North Carolina
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 60 and over
Trial IDs: Pro00064813, NCI-2015-01565, NCT02510716
Nicotine Delivery from Novel Non-Tobacco Electronic System in Smokers
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 55
Trial IDs: I 257514, NCI-2015-01187, NCT02575885
Smoking-cessation: A Spanish-Language Clinical Trial
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 and over
Trial IDs: MCC-18231, NCI-2015-02160, NCT02611076
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
Status: Not yet active
Phase: No phase specified
Type: Prevention
Age: 18 to 75
Trial IDs: 2015-0879, NCI-2016-00674, NCT02697227
Start Over